MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.virs.2025.09.001

Медицинская библиотека · Virologica Sinica · 2025

A safe and broad-spectrum SARS-CoV-2 mRNA vaccine with a new delivery system for in-situ expression.

Yu Weiyi, Chen Xianying, Chen Qiubing, Chen Peixuan, Liu Naizhang, Li Yingjian, Tan Xue, Zhang Qiuhan, Rao Yan, Guo Ming, Huang Zhixiang, Wang Xin, Zhang Zhen, Xiang Wenjie, Zhang Yuzhen, Liu Qianyun, Yin Hao, Zhou Li, Chen Yu, Lan Ke

СтатьяПеревод в очереди

Аннотация

Since the outbreak of COVID-19 in late 2019, the cumulative number of confirmed cases worldwide has surpassed 778 million, and the number of deaths has exceeded 7 million, posing a significant threat to human life and health while inflicting enormous losses on the global economy. At the stage where sequential immunization is recommended, there is a pressing demand for mRNA vaccines that can be rapidly adapted to new sequences, are easy to industrialize, and exhibit high safety and effectiveness. We developed a lipid nanoparticle (LNP) system, designated as WNP, which facilitates essentially in situ expression at the injection site and results in lower levels of pro-inflammatory factors in the liver, thus enhancing its safety compared to liver-targeted alternatives. Furthermore, in light of the swiftly mutating characteristic of SARS-CoV-2, a study has used cross-lineage chimeras and mutation patch strategies to design an antigen that is highly immunogenic and can stimulate the production of a broad range of effective antibodies. Therefore, we used the same antigenic configuration of RBD including five key mutation sites (K417T, L452R, T478K, E484K, and N501Y) to achieve optimal broad-spectrum efficacy. Our results indicate that WNP can elicit a humoral immunity response that is as robust as that of SM-102, a stronger cellular immune response, and provide a certain protective effect. On top of that, WNP can be applied to the development of vaccines targeting other pathogens and will contribute to a quicker response to the spillovers of unknown mammalian viruses.

Для цитирования: Yu Weiyi, Chen Xianying, Chen Qiubing, Chen Peixuan, Liu Naizhang, Li Yingjian, Tan Xue, Zhang Qiuhan, Rao Yan, Guo Ming, Huang Zhixiang, Wang Xin, Zhang Zhen, Xiang Wenjie, Zhang Yuzhen, Liu Qianyun, Yin Hao, Zhou Li, Chen Yu, Lan Ke. A safe and broad-spectrum SARS-CoV-2 mRNA vaccine with a new delivery system for in-situ expression.. Virologica Sinica. 2025. DOI: 10.1016/j.virs.2025.09.001.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.